Table of Content

1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Scope
1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
1.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 XIFAXAN
1.2.3 Viberzi
1.2.4 Lotronex
1.2.5 Other
1.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel
1.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Comparison by Sales Channel (2016 & 2021 & 2027)
1.3.2 Hospitals Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trends (2016-2027)

2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Forecasts by Region
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2016-2027)
2.4.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2016-2027)
2.4.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2016-2027)
3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Competition Landscape by Players
3.1 Global Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players by Sales (2016-2021)
3.2 Global Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players by Revenue (2016-2021)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs as of 2020)
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Type (2022-2027)
5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Sales Channel
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Review by Sales Channel (2016-2021)
5.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
5.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2016-2021)
5.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Sales Channel (2016-2021)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts by Sales Channel (2022-2027)
5.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Sales Channel (2022-2027)
5.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Sales Channel (2022-2027)
5.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Sales Channel (2022-2027)

6 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
6.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company
6.1.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2021)
6.1.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021)
6.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type
6.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel
6.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel (2016-2021)
6.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel (2022-2027)

7 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company
7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2021)
7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021)
7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type
7.2.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel
7.3.1 Europe 137 Sales Breakdown by Sales Channel (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Sales Channel (2022-2027)

8 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
8.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company
8.1.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2021)
8.1.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021)
8.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type
8.2.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2022-2027)
8.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel
8.3.1 China 243 Sales Breakdown by Sales Channel (2016-2021)
8.3.2 China 243 Sales Breakdown by Sales Channel (2022-2027)

9 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
9.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company
9.1.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2021)
9.1.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021)
9.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type
9.2.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel
9.3.1 Japan Jan. Sales Breakdown by Sales Channel (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Sales Channel (2022-2027)

10 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
10.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company
10.1.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel
10.3.1 Southeast Asia K Units Sales Breakdown by Sales Channel (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Sales Channel (2022-2027)

11 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
11.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company
11.1.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2021)
11.1.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021)
11.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type
11.2.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Type (2022-2027)
11.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel
11.3.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel (2016-2021)
11.3.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Breakdown by Sales Channel (2022-2027)

12 Company Profiles and Key Figures in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business
12.1 Bausch Health
12.1.1 Bausch Health Corporation Information
12.1.2 Bausch Health Business Overview
12.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.1.5 Bausch Health Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.2.5 Allergan Recent Development
12.3 Sebela Pharmaceuticals
12.3.1 Sebela Pharmaceuticals Corporation Information
12.3.2 Sebela Pharmaceuticals Business Overview
12.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.3.5 Sebela Pharmaceuticals Recent Development
12.4 Astellas Pharmaceuticals
12.4.1 Astellas Pharmaceuticals Corporation Information
12.4.2 Astellas Pharmaceuticals Business Overview
12.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.4.5 Astellas Pharmaceuticals Recent Development
12.5 Amneal Pharms
12.5.1 Amneal Pharms Corporation Information
12.5.2 Amneal Pharms Business Overview
12.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.5.5 Amneal Pharms Recent Development
12.6 Pharscin Pharma
12.6.1 Pharscin Pharma Corporation Information
12.6.2 Pharscin Pharma Business Overview
12.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.6.5 Pharscin Pharma Recent Development
...

13 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis
13.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
13.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
14.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers

15 Market Dynamics
15.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trends
15.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Drivers
15.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges
15.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales ((US$ Million)) Comparison by Sales Channel (2016 & 2021 & 2027)
Table 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Region (2016-2021)
Table 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Company (2016-2021)
Table 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Company (2016-2021)
Table 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs as of 2020)
Table 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2016-2021)
Table 23. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2022-2027)
Table 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2022-2027)
Table 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Sales Channel (2016-2021)
Table 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Sales Channel (2016-2021)
Table 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Sales Channel (2016-2021)
Table 32. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Sales Channel (2016-2021)
Table 33. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Sales Channel (2022-2027)
Table 34. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Sales Channel (2022-2027)
Table 35. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Sales Channel (2022-2027)
Table 36. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Sales Channel (2022-2027)
Table 37. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Sales Channel (2022-2027)
Table 38. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 47. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 48. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2022-2027) & (K Units)
Table 49. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2022-2027)
Table 50. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 59. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 60. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2022-2027) & (K Units)
Table 61. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2022-2027)
Table 62. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2021)
Table 64. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 68. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2022-2027)
Table 70. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 71. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 72. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2022-2027) & (K Units)
Table 73. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2022-2027)
Table 74. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 83. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 84. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2022-2027) & (K Units)
Table 85. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2022-2027)
Table 86. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 95. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 96. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2022-2027) & (K Units)
Table 97. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2022-2027)
Table 98. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2021)
Table 100. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 104. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2022-2027)
Table 106. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 107. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 108. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2022-2027) & (K Units)
Table 109. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2022-2027)
Table 110. Bausch Health Corporation Information
Table 111. Bausch Health Description and Business Overview
Table 112. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 114. Bausch Health Recent Development
Table 115. Allergan Corporation Information
Table 116. Allergan Description and Business Overview
Table 117. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 119. Allergan Recent Development
Table 120. Sebela Pharmaceuticals Corporation Information
Table 121. Sebela Pharmaceuticals Description and Business Overview
Table 122. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 124. Sebela Pharmaceuticals Recent Development
Table 125. Astellas Pharmaceuticals Corporation Information
Table 126. Astellas Pharmaceuticals Description and Business Overview
Table 127. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 129. Astellas Pharmaceuticals Recent Development
Table 130. Amneal Pharms Corporation Information
Table 131. Amneal Pharms Description and Business Overview
Table 132. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 134. Amneal Pharms Recent Development
Table 135. Pharscin Pharma Corporation Information
Table 136. Pharscin Pharma Description and Business Overview
Table 137. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 139. Pharscin Pharma Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table 143. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers List
Table 144. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trends
Table 145. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers
Table 146. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges
Table 147. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture
Figure 2. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2021 & 2027
Figure 6. Hospitals Pharmacy Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Market Share by Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs: 2016 & 2020
Figure 28. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Sales Channel (2016-2021)
Figure 32. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate by Sales Channel in 2016 & 2020
Figure 33. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 34. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 35. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 36. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 37. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 38. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 39. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 40. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 41. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 43. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 44. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 47. Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 48. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed